case_study
    2022

    A detailed regimen of isotretinoin for the successful treatment of severe keratosis pilaris

    Kirchner A, Hoyer S

    Published in Clinical and Experimental Dermatology

    Methodology

    Single-patient case report describing a staged oral isotretinoin dosing regimen for severe keratosis pilaris, with clinical photographic follow-up.

    Key Findings

    A detailed oral isotretinoin regimen produced marked clearance of severe, treatment-resistant keratosis pilaris in a single patient; the authors emphasise that no controlled trials support this indication.

    Conclusions

    A single case report of oral isotretinoin for severe keratosis pilaris; the authors note no controlled studies of this approach exist.

    Limitations

    Single case with no control or blinding, unquantified outcome, unknown durability after cessation, and isotretinoin carries significant teratogenic and systemic risks.

    Related Health Concerns

    Study Details

    Year:2022
    Sample Size:1
    Quality Score:3/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.